NO20044554L - Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener - Google Patents

Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener

Info

Publication number: NO20044554L
Authority: NO; Norway
Prior art keywords: melagatran; combination product; oxabispidens; antiarrhythmic; compound
Prior art date: 2002-05-06

Application number

NO20044554A

Other languages

English (en)

Norwegian (no)

Inventor

Elisabeth Svernhage

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-06

Filing date

2004-10-22

Publication date

2004-11-16

2004-10-22 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-11-16 Publication of NO20044554L publication Critical patent/NO20044554L/no

Links

239000013066 combination product Substances 0.000 title abstract 2
229940127555 combination product Drugs 0.000 title abstract 2
DKWNMCUOEDMMIN-PKOBYXMFSA-N melagatran Chemical compound C1=CC(C(=N)N)=CC=C1CNC(=O)[C@H]1N(C(=O)[C@H](NCC(O)=O)C2CCCCC2)CC1 DKWNMCUOEDMMIN-PKOBYXMFSA-N 0.000 title abstract 2
229960002137 melagatran Drugs 0.000 title abstract 2
230000003288 anthiarrhythmic effect Effects 0.000 title 1
239000003416 antiarrhythmic agent Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 2
229940126062 Compound A Drugs 0.000 abstract 1
NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 abstract 1
206010003119 arrhythmia Diseases 0.000 abstract 1
230000006793 arrhythmia Effects 0.000 abstract 1
230000015271 coagulation Effects 0.000 abstract 1
238000005345 coagulation Methods 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines having two or more nitrogen atoms in the same ring, e.g. oxadiazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20044554A 2002-05-06 2004-10-22 Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener NO20044554L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE0201373A SE0201373D0 (sv)	2002-05-06	2002-05-06	Combination therapy
PCT/SE2003/000720 WO2003092721A1 (en)	2002-05-06	2003-05-05	A combination product comprising melagatran and an anti-arrhythmic oxabispidenes

Publications (1)

Publication Number	Publication Date
NO20044554L true NO20044554L (no)	2004-11-16

Family

ID=20287788

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044554A NO20044554L (no)	2002-05-06	2004-10-22	Kombinasjonsprodukt omfattende melagatran og anti-arrytmiske oksabispidener

Country Status (19)

Country	Link
US (1)	US20060074080A1 (is)
EP (1)	EP1503782A1 (is)
JP (1)	JP2005531546A (is)
KR (1)	KR20050007470A (is)
CN (1)	CN1652811A (is)
AR (1)	AR039572A1 (is)
AU (1)	AU2003224590A1 (is)
BR (1)	BR0309354A (is)
CA (1)	CA2483001A1 (is)
IL (1)	IL164869A0 (is)
IS (1)	IS7561A (is)
MX (1)	MXPA04010716A (is)
NO (1)	NO20044554L (is)
PL (1)	PL372368A1 (is)
RU (1)	RU2004129730A (is)
SE (1)	SE0201373D0 (is)
TW (1)	TW200403071A (is)
WO (1)	WO2003092721A1 (is)
ZA (1)	ZA200408615B (is)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE9903759D0 (sv) *	1999-10-18	1999-10-18	Astra Ab	Pharmaceutically active compounds
US6462021B1 (en) *	2000-11-06	2002-10-08	Astrazeneca Ab	Use of low molecular weight thrombin inhibitor

2002
- 2002-05-06 SE SE0201373A patent/SE0201373D0/xx unknown
2003
- 2003-05-02 TW TW092112174A patent/TW200403071A/zh unknown
- 2003-05-05 AU AU2003224590A patent/AU2003224590A1/en not_active Abandoned
- 2003-05-05 EP EP03721266A patent/EP1503782A1/en not_active Withdrawn
- 2003-05-05 CA CA002483001A patent/CA2483001A1/en not_active Abandoned
- 2003-05-05 MX MXPA04010716A patent/MXPA04010716A/es unknown
- 2003-05-05 CN CNA038102129A patent/CN1652811A/zh active Pending
- 2003-05-05 JP JP2004500904A patent/JP2005531546A/ja active Pending
- 2003-05-05 RU RU2004129730/15A patent/RU2004129730A/ru not_active Application Discontinuation
- 2003-05-05 KR KR10-2004-7017782A patent/KR20050007470A/ko not_active Withdrawn
- 2003-05-05 WO PCT/SE2003/000720 patent/WO2003092721A1/en not_active Ceased
- 2003-05-05 PL PL03372368A patent/PL372368A1/xx not_active Application Discontinuation
- 2003-05-05 BR BR0309354-9A patent/BR0309354A/pt not_active IP Right Cessation
- 2003-05-05 US US10/513,187 patent/US20060074080A1/en not_active Abandoned
- 2003-05-06 AR ARP030101594A patent/AR039572A1/es unknown
2004
- 2004-10-22 NO NO20044554A patent/NO20044554L/no not_active Application Discontinuation
- 2004-10-25 ZA ZA200408615A patent/ZA200408615B/en unknown
- 2004-10-27 IL IL16486904A patent/IL164869A0/xx unknown
- 2004-11-29 IS IS7561A patent/IS7561A/is unknown

Also Published As

Publication number	Publication date
WO2003092721A1 (en)	2003-11-13
SE0201373D0 (sv)	2002-05-06
BR0309354A (pt)	2005-02-15
US20060074080A1 (en)	2006-04-06
IL164869A0 (en)	2005-12-18
IS7561A (is)	2004-11-29
PL372368A1 (en)	2005-07-25
AU2003224590A1 (en)	2003-11-17
JP2005531546A (ja)	2005-10-20
AR039572A1 (es)	2005-02-23
EP1503782A1 (en)	2005-02-09
CN1652811A (zh)	2005-08-10
KR20050007470A (ko)	2005-01-18
RU2004129730A (ru)	2005-07-10
TW200403071A (en)	2004-03-01
MXPA04010716A (es)	2005-03-07
ZA200408615B (en)	2006-04-26
CA2483001A1 (en)	2003-11-13

Similar Documents

Publication	Publication Date	Title
GEP20043269B (en)	2004-06-25	Purine Derivatives, Method for Their Production and Composition Containing the Same
NO20042161L (no)	2004-08-17	Inhibitorer av 11-beta-hydroksysteroid dehydrogenase type 1
MXPA04001889A (es)	2004-06-15	Inhibidores de la alquin-aril fosfodiesterasa-4.
GEP20043324B (en)	2004-04-13	Purine Derivatives
EP1268412B8 (en)	2007-02-21	Sulphonamido-substituted bridged bicycloalkyl derivatives
IL165264A (en)	2011-07-31	Protein kinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for treating protein kinase-associated diseases
NO20051600L (no)	2005-06-13	1,4-disubstituerte piperidinderivater og anvendelse derav som 11-betaHSD1 inhibitorer
NO20054852L (no)	2005-12-13	GFAT inhibitorer
AU2003301020A1 (en)	2004-07-22	Isoquinolinone derivatives and their use as therapeutic agents
AU2002239830A1 (en)	2003-07-24	Pyruvate cardioplegia solutions for administration to the heart during cardiopulmonary surgery and methods of use thereof
WO2004072031A8 (en)	2005-10-06	Phenylacetamides and their use as glucokinase modulators
AU2003233010A8 (en)	2003-12-19	Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
NO20060971L (no)	2006-05-02	Pyridazinderivater og deres anvendelse som terapeutiske midler
CA2258217A1 (en)	1997-12-18	Substituted cyclopentane compounds useful as neuraminidase inhibitors
HK1046527A1 (zh)	2003-01-17	金剛烷衍生物
NO20035210L (no)	2003-11-27	2-anilino-pyrimidinderivater som cyklinavhengige kinaseinhibitorer
NO20055565L (no)	2006-01-25	Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
MXPA05003253A (es)	2005-06-08	Nuevos derivados de pirimidinamida y el uso de los mismos.
MY140164A (en)	2009-11-30	Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
NO20050662L (no)	2005-04-15	COX-2 inhiberende pyridinderivater
PE20030061A1 (es)	2003-02-08	1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
PL377237A1 (pl)	2006-01-23	4-okso-1-(3-podstawiony fenyl)-1,4- dihydro-1,8-naftyrydyno-3- karboksyamidy jako inhibitory fosfodiesterazy-4
WO2002070469A3 (en)	2004-03-04	Selective pde3b inhibitors and use of the same in therapy
AU2003224747A1 (en)	2003-10-27	Technetium-labeled rotenone derivatives, and methods of use thereof
NO20016201L (no)	2001-12-18	Tienopyrimidiner som fosfodiesteraseinhibitorer

Legal Events

Date	Code	Title	Description
2006-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application